Skip to main content
Erschienen in: Surgical Endoscopy 12/2012

01.12.2012

Laparoscopic Roux-en-Y gastric bypass: long term clinical outcomes

verfasst von: Ayman Obeid, Joshua Long, Manasi Kakade, Ronald H. Clements, Richard Stahl, Jayleen Grams

Erschienen in: Surgical Endoscopy | Ausgabe 12/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Bariatric surgery remains the most effective treatment for morbid obesity, and laparoscopic Roux-en-Y gastric bypass (LRYGB) continues to be the preferred operation. However, data for long-term outcomes are lacking. Our goal was to determine the long-term clinical outcomes after LRYGB.

Methods

Retrospective review of a prospectively maintained database was conducted on all patients who underwent LRYGB from 2001–2006. Only patients who had postoperative clinic visits both at ≤2 and ≥5 years were included. Data collected included patient demographics and postoperative clinical outcomes, including percent excess weight loss (%EWL), complications, and improvement or resolution of preoperative comorbidities (type 2 diabetes mellitus, hypertension, obstructive sleep apnea, and hyperlipidemia). Data were analyzed by using SAS (version 9.2) and SPSS (version 16) statistical software.

Results

There were 770 patients who underwent LRYGB at UAB from 2001–2006. Of these, 172 patients met inclusion criteria (148 women and 24 men) with a median age of 41 years and median body mass index of 46 kg/m2. Median short- and long-term follow-up was 12 and 75 months, respectively. Mean %EWL was 69 % for short-term and 65 % for long-term follow-up (P = 0.0032). Of 172 patients, 66 experienced 81 complications at a median of 26 months after operation. The improvement or resolution of comorbidities was maintained in the long-term, and there was no statistically significant difference compared with improvement or resolution in the short-term.

Conclusions

Although there was a statistically significant difference in %EWL between short- and long-term follow-up, both arms showed a clinically relevant %EWL (69 and 65 %) and both were statistically significant compared with preoperative values. The improvement or resolution of comorbidities achieved with LRYGB was maintained in long-term follow-up. Thus, LRYGB resulted in significant improvement in clinical outcomes that were durable in the long term.
Literatur
1.
Zurück zum Zitat Wang Y, Beydoun MA (2007) The obesity epidemic in the United States: gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 29:6–28PubMedCrossRef Wang Y, Beydoun MA (2007) The obesity epidemic in the United States: gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 29:6–28PubMedCrossRef
2.
Zurück zum Zitat Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 307(5):491–497PubMedCrossRef Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 307(5):491–497PubMedCrossRef
3.
Zurück zum Zitat Kopelman PG (2000) Obesity as a medical problem. Nature 404:635–643PubMed Kopelman PG (2000) Obesity as a medical problem. Nature 404:635–643PubMed
4.
Zurück zum Zitat Kenchaiah S, Evans JC, Levy D, Wilson PWF, Benjamin EJ, Larson MG, Kannel WB, Vasan RS (2002) Obesity and the risk of heart failure. N Engl J Med 347:305–313PubMedCrossRef Kenchaiah S, Evans JC, Levy D, Wilson PWF, Benjamin EJ, Larson MG, Kannel WB, Vasan RS (2002) Obesity and the risk of heart failure. N Engl J Med 347:305–313PubMedCrossRef
5.
Zurück zum Zitat Deprés J-P, Lemieux I (2006) Abdominal obesity and metabolic syndrome. Nature 444:881–887CrossRef Deprés J-P, Lemieux I (2006) Abdominal obesity and metabolic syndrome. Nature 444:881–887CrossRef
6.
Zurück zum Zitat Van Gaal LF, Mertens IL, DeBlock CE (2006) Mechanisms linking obesity with cardiovascular disease. Nature 444:875–880PubMedCrossRef Van Gaal LF, Mertens IL, DeBlock CE (2006) Mechanisms linking obesity with cardiovascular disease. Nature 444:875–880PubMedCrossRef
7.
Zurück zum Zitat Ärnlöv J, Ingelsson E, Sundström J, Lind L (2010) Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 131:230–236CrossRef Ärnlöv J, Ingelsson E, Sundström J, Lind L (2010) Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 131:230–236CrossRef
8.
Zurück zum Zitat Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A, Leitzmann MF (2006) Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 355:763–778PubMedCrossRef Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A, Leitzmann MF (2006) Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 355:763–778PubMedCrossRef
9.
Zurück zum Zitat Freedman DM, Ron E, Ballard-Barbash R, Doody MM, Linet MS (2006) Body mass index and all-cause mortality in a nationwide US cohort. Int J Obes 30:822–829CrossRef Freedman DM, Ron E, Ballard-Barbash R, Doody MM, Linet MS (2006) Body mass index and all-cause mortality in a nationwide US cohort. Int J Obes 30:822–829CrossRef
10.
Zurück zum Zitat Christou NV, Sampalis JS, Liberman M, Look D, Auger S, McLean APH, MacLean LD (2004) Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 240:416–423PubMedCrossRef Christou NV, Sampalis JS, Liberman M, Look D, Auger S, McLean APH, MacLean LD (2004) Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 240:416–423PubMedCrossRef
11.
Zurück zum Zitat Flum DR, Dellinger EP (2004) Impact of gastric bypass operation on survival: a population- based analysis. J Am Coll Surg 199:543–551PubMedCrossRef Flum DR, Dellinger EP (2004) Impact of gastric bypass operation on survival: a population- based analysis. J Am Coll Surg 199:543–551PubMedCrossRef
12.
Zurück zum Zitat Sjöström L, Narbro K, Sjöström DC, Karason K, Larsson B, Wedel H et al (2007) Effects of bariatric surgery on mortality in swedish obese subjects. N Engl J Med 357:741–752PubMedCrossRef Sjöström L, Narbro K, Sjöström DC, Karason K, Larsson B, Wedel H et al (2007) Effects of bariatric surgery on mortality in swedish obese subjects. N Engl J Med 357:741–752PubMedCrossRef
13.
Zurück zum Zitat Schauer PR, Ikramuddin S, Gourash W, Ramanathan R, Luketich J (2000) Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg 232:515–529PubMedCrossRef Schauer PR, Ikramuddin S, Gourash W, Ramanathan R, Luketich J (2000) Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg 232:515–529PubMedCrossRef
14.
Zurück zum Zitat Sjostrom L, Peltonen M, Jacobson P, Sjostrom DC, Karason K, Wedel H et al (2012) Bariatric surgery and long-term cardiovascular events. JAMA 307:56–65PubMedCrossRef Sjostrom L, Peltonen M, Jacobson P, Sjostrom DC, Karason K, Wedel H et al (2012) Bariatric surgery and long-term cardiovascular events. JAMA 307:56–65PubMedCrossRef
15.
16.
Zurück zum Zitat Scott WR, Batterham RL (2011) Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery. Am J Physiol Regul Integr Comp Physiol 301:R15–R27PubMedCrossRef Scott WR, Batterham RL (2011) Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery. Am J Physiol Regul Integr Comp Physiol 301:R15–R27PubMedCrossRef
17.
Zurück zum Zitat Sjöström L (2008) Bariatric surgery and reduction in morbidity and mortality: experiences from the SOS study. Int J Obes 32:S93–S97CrossRef Sjöström L (2008) Bariatric surgery and reduction in morbidity and mortality: experiences from the SOS study. Int J Obes 32:S93–S97CrossRef
18.
Zurück zum Zitat Wolfe BM, Elder KA (2007) Bariatric surgery: review of procedures. Gastroenterology 132:2253–2271PubMedCrossRef Wolfe BM, Elder KA (2007) Bariatric surgery: review of procedures. Gastroenterology 132:2253–2271PubMedCrossRef
19.
Zurück zum Zitat Pournaras DJ, Aasheim ET, Søvik TT, Andrews R, Mahon D, Welbourn R, Olbers T, le Roux CW (2012) Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders. Br J Sur 99:110–130CrossRef Pournaras DJ, Aasheim ET, Søvik TT, Andrews R, Mahon D, Welbourn R, Olbers T, le Roux CW (2012) Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders. Br J Sur 99:110–130CrossRef
20.
Zurück zum Zitat Spivak H, Abdelmelek MF, Beltran OR, Ng AW, Kitahama S (2012) Long-term outcomes of laparoscopic adjustable gastric banding and laparoscopic Roux-en-Y gastric bypass in the United States. Surg Endosc. doi:10.1007/s00464-011-2125-z Spivak H, Abdelmelek MF, Beltran OR, Ng AW, Kitahama S (2012) Long-term outcomes of laparoscopic adjustable gastric banding and laparoscopic Roux-en-Y gastric bypass in the United States. Surg Endosc. doi:10.​1007/​s00464-011-2125-z
21.
22.
Zurück zum Zitat Higa K, Ho T, Tercero F, Yunus T, Boone KB (2011) Laparoscopic roux-en-Y gastric bypass: 10 year follow-up. Surg Obes Relat Dis 7:516–525PubMedCrossRef Higa K, Ho T, Tercero F, Yunus T, Boone KB (2011) Laparoscopic roux-en-Y gastric bypass: 10 year follow-up. Surg Obes Relat Dis 7:516–525PubMedCrossRef
23.
Zurück zum Zitat Wittgrove AC, Clark GW (2000) Laparoscopic gastric bypass, Roux-en-Y—500 patients: technique and results, with 3–60 month follow-up. Obes Surg 10:233–239PubMedCrossRef Wittgrove AC, Clark GW (2000) Laparoscopic gastric bypass, Roux-en-Y—500 patients: technique and results, with 3–60 month follow-up. Obes Surg 10:233–239PubMedCrossRef
24.
Zurück zum Zitat Angrisani L, Lorenzo M, Borrelli V (2007) Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial. Surg Obes Relat Dis 3:127–132PubMedCrossRef Angrisani L, Lorenzo M, Borrelli V (2007) Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial. Surg Obes Relat Dis 3:127–132PubMedCrossRef
25.
Zurück zum Zitat Suter M, Donadini A, Romy S, Demartines N, Giusti V (2011) Laparoscopic Roux-en-Y gastric bypass significant long-term weight loss, improvement of obesity-related comorbidities and quality of life. Ann Surg 254:267–273PubMedCrossRef Suter M, Donadini A, Romy S, Demartines N, Giusti V (2011) Laparoscopic Roux-en-Y gastric bypass significant long-term weight loss, improvement of obesity-related comorbidities and quality of life. Ann Surg 254:267–273PubMedCrossRef
26.
Zurück zum Zitat Christou N, Efthimiou E (2009) Five-year outcomes of laparoscopic adjustable gastric banding and laparoscopic Roux-en-Y gastric bypass in a comprehensive bariatric surgery program in Canada. Can J Surg 52:E249–E258PubMed Christou N, Efthimiou E (2009) Five-year outcomes of laparoscopic adjustable gastric banding and laparoscopic Roux-en-Y gastric bypass in a comprehensive bariatric surgery program in Canada. Can J Surg 52:E249–E258PubMed
27.
Zurück zum Zitat Boza C, Gamboa C, Awruch D, Perez G, Escalona A, Ibanez L (2010) Laparoscopic Roux-en-Y gastric bypass versus laparoscopic adjustable gastric banding: five years of follow-up. Surg Obes Relat Dis 6:470–475PubMedCrossRef Boza C, Gamboa C, Awruch D, Perez G, Escalona A, Ibanez L (2010) Laparoscopic Roux-en-Y gastric bypass versus laparoscopic adjustable gastric banding: five years of follow-up. Surg Obes Relat Dis 6:470–475PubMedCrossRef
28.
Zurück zum Zitat Boza C, Gamboa C, Salinas J, Achurra P, Vega A, Pérez G (2011) Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy: a case-control study and 3 years of follow-up. Surg Obes Relat Dis. doi:10.1016/j.soard.2011.08.023 Boza C, Gamboa C, Salinas J, Achurra P, Vega A, Pérez G (2011) Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy: a case-control study and 3 years of follow-up. Surg Obes Relat Dis. doi:10.​1016/​j.​soard.​2011.​08.​023
29.
Zurück zum Zitat DiGiorgi M, Rosen DJ, Choi JJ, Milone L, Schrope B, Olivero-Rivera L et al (2010) Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up. Surg Obes Relat Dis 6:249–253PubMedCrossRef DiGiorgi M, Rosen DJ, Choi JJ, Milone L, Schrope B, Olivero-Rivera L et al (2010) Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up. Surg Obes Relat Dis 6:249–253PubMedCrossRef
30.
Zurück zum Zitat Sugerman HJ, Wolfe LG, Sica DA, Clore JN (2003) Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 237:751–758PubMed Sugerman HJ, Wolfe LG, Sica DA, Clore JN (2003) Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 237:751–758PubMed
31.
Zurück zum Zitat Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K (2010) Bariatric surgery: a systematic review and meta-analysis. JAMA 292:1724–1737CrossRef Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K (2010) Bariatric surgery: a systematic review and meta-analysis. JAMA 292:1724–1737CrossRef
32.
Zurück zum Zitat Weber M, Müller MK, Bucher T, Wildi S, Dindo D, Horber F, Hauser R, Clavien PA (2004) Laparoscopic gastric bypass is superior to laparoscopic gastric banding for treatment of morbid obesity. Ann Surg 240:975–982PubMedCrossRef Weber M, Müller MK, Bucher T, Wildi S, Dindo D, Horber F, Hauser R, Clavien PA (2004) Laparoscopic gastric bypass is superior to laparoscopic gastric banding for treatment of morbid obesity. Ann Surg 240:975–982PubMedCrossRef
33.
Zurück zum Zitat Mognol P, Chosidow D, Marmuse JP (2005) Laparoscopic gastric bypass versus laparoscopic adjustable gastric banding in the super-obese: a comparative study of 290 patients. Obes Surg 15:76–81PubMedCrossRef Mognol P, Chosidow D, Marmuse JP (2005) Laparoscopic gastric bypass versus laparoscopic adjustable gastric banding in the super-obese: a comparative study of 290 patients. Obes Surg 15:76–81PubMedCrossRef
Metadaten
Titel
Laparoscopic Roux-en-Y gastric bypass: long term clinical outcomes
verfasst von
Ayman Obeid
Joshua Long
Manasi Kakade
Ronald H. Clements
Richard Stahl
Jayleen Grams
Publikationsdatum
01.12.2012
Verlag
Springer-Verlag
Erschienen in
Surgical Endoscopy / Ausgabe 12/2012
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-012-2375-4

Weitere Artikel der Ausgabe 12/2012

Surgical Endoscopy 12/2012 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.